Last reviewed · How we verify
NCT06327217
Long Term Results After Hip Arthroscopy
trial testing Bilateral hip x-ray in Femoro Acetabular Impingement in 451 participants. Status unknown.
1 March 2025
Quick facts
| Lead sponsor | Reinier Haga Orthopedisch Centrum |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 451 |
| Start date | 1 April 2024 |
| Primary completion | 1 March 2025 |
| Estimated completion | 1 March 2025 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- Bilateral hip x-ray
- Questionnaires
Conditions studied
- Femoro Acetabular Impingement — all drugs for Femoro Acetabular Impingement →
Sponsor
Reinier Haga Orthopedisch Centrum
Who can join
16 and older, any sex, with Femoro Acetabular Impingement. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A common cause of hip joint pain in the young and active population is femoroacetabular impingement (FAI) syndrome. if FAI is left untreated, the changed morphology will have a negative effect on the existing joint and will contribute to the development of osteoarthritis (OA). Hip arthroscopy is the first choice of operative treatment for FAI. While hip arthroscopy improves the patient reported outcome measures (PROMs), the influence of this treatment on the contribution to the development of osteoarthritis after FAI is to the best of our knowledge still unknown.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06327217
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Femoro Acetabular Impingement
Currently open trials in the same condition.
- NCT06288867 — A 12 Months Prospective Study Comparing Functional Outcome Scores in Hip Arthroscopic Labral Repair Versus Debridement · NA · recruiting
- NCT06003101 — Effect of PRP, PPP, & BMAC on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies · Phase 3 · recruiting
- NCT05280899 — Weightbearing Restrictions on Postoperative Outcomes Following Arthroscopic Surgery for FAI · NA · recruiting
- NCT03909139 — Use of BMAC With Hip Arthroscopy Treatment of FAI and Labral Tear · recruiting
Other Reinier Haga Orthopedisch Centrum trials
Trials by the same sponsor.
- NCT07070570 — HAKA: Routine Follow-up at 10 Years After Hip- or Knee Arthroplasty: Wasting Resources or Appropriate Healthcare? · NA · not yet recruiting
- NCT06654349 — Short-term Recovery After Trapeziectomy and TMC Prosthesis: a Diary Study · recruiting
- NCT06275776 — HIP-STITCH (Wound Recovery After THA) · NA · recruiting
- NCT06885411 — Ototoxicity in Patients With MoM Hip Bearings · recruiting
- NCT05638386 — Effect of Plugging the Registration Pin Tract in Robotic-assisted Knee Surgery · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06327217 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Reinier Haga Orthopedisch Centrum
- Last refreshed: 25 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06327217.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing